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Abstract
Hypokalemic Periodic Paralysis is one form of Periodic Paralysis, a rare group of disorders that can
cause of sudden onset weakness. A case of a 29 year old male is presented here. The patient
presented with sudden onset paralysis of his extremities. Laboratory evaluation revealed a
markedly low potassium level. The patient's paralysis resolved upon repletion of his low potassium
and he was discharged with no neurologic deficits. An association with thyroid disease is well
established and further workup revealed Grave's disease in this patient. Although rare, Periodic
Paralysis must differentiated from other causes of weakness and paralysis so that the proper
treatment can be initiated quickly.
Case presentation
A 29 year-old Hispanic male with no significant past med-
ical history presented to the emergency room with sudden
onset paralysis. The patient had gone to bed at 10 pm with
no weakness and awoke at midnight unable to move his
upper or lower extremities. The weakness was bilateral
and involved both the proximal muscles of the shoulders
and hips as well as the distal extremities. He had no respi-
ratory or swallowing difficulty and was able to move his
neck and facial muscles. He denied any pain or paresthe-
sia. Prior to this episode, the patient had been healthy and
denied any recent diarrhea, chest pain, shortness of
breath, or weight change. He did report several episodes
of waking from sleep with a "racing heart." He did not
take any medications and denied use of alcohol or drugs,
or significant changes in diet or activity levels. His mother
had been diagnosed with hypothyroidism but his parents
and brother had no history of similar episodes and no
other significant illnesses.
On physical exam, the patient's heart rate was 124 and
blood pressure was 193/81. He was mildly obese, but oth-
erwise normal in overall appearance. His skin was cool
and dry, and the oral mucosa was moist. No jugular
venous distension, goiter or lymphadenopathy were
appreciated. Cardiac exam revealed tachycardia with a reg-
ular rhythm and no murmurs. Examination of the lungs
and abdomen were unremarkable. There were no deform-
ities or edema of the extremities and distal pulses were
present and equal bilaterally. Neurologic exam revealed
flaccid paralysis of all extremities which involved the
proximal and distal muscles and included the hips and
shoulders. Sensation was intact but deep tendon reflexes
were slightly diminished to 3 out of 4 throughout. Cranial
nerve function was grossly intact.
Routine chemistry, liver enzymes and complete blood
count were normal except for a potassium level of 1.6
(3.5–5 mmol/L). Electrocardiogram revealed sinus tachy-
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cardia with Mobitz Type 1 atrio-ventricular block (Figure
1).
Two hours after initiation of intravenous potassium
replacement, the patient's neurologic symptoms had com-
pletely resolved. His blood pressure remained elevated at
174/86, however repeat electrocardiogram revealed a nor-
mal sinus rhythm and rate. Follow up studies were per-
formed to determine the etiology of the patient's
hypokalemia. Urine sodium and potassium, and serum
aldosterone and renin levels were measured to rule out
adrenal involvement and were found to be normal. Thy-
roid stimulating hormone (TSH), triiodothyronine (T3)
and thyroxine (T4) levels were obtained and revealed a
markedly abnormal TSH of 0.01 (0.3–5.5 IU/mL) with
elevated T3 of 300 (65–164 ng/dL) and T4 of 3.71 (0.58–
1.64 ng/dL). Iodine-123 thyroid scan subsequently dem-
onstrated an asymmetric enlargement of the right lobe of
the thyroid gland with significantly increased uptake at 2
and 24 hours.
The patient was diagnosed with Hypokalemic Periodic
Paralysis associated with Grave's Disease and was started
on methimazole for control of his underlying hyperthy-
roidism and a beta-blocker for control of blood pressure
and tachycardia. He was discharged home with an
appointment to follow up with an endocrinologist.
Discussion
Weakness is a common, albeit non-specific, presentation
in both the emergency and outpatient setting. Although
the differential diagnosis for the complaint of weakness is
extensive (Table 1), the focus is considerably narrowed
when a patient presents with a demonstrable decrease in
Progression of EKG Findings Figure 1
Progression of EKG Findings. (A) The initial EKG revealed Mobitz Type I heart block. Several p-waves (solid arrows) are 
present that are not associated with a QRS complex. The duration of the PR interval continues to increase until a QRS is 
skipped (open arrow). (B) After treatment, the EKG revealed a return to a sinus rhythm.
A.  EKG # 1 - Mobitz Type I atrio-ventricular block
B.  EKG # 2 - Sinus TachycardiaCases Journal 2008, 1:256 http://www.casesjournal.com/content/1/1/256
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muscle strength on physical exam. Strokes and tumors
causing nerve compression are potentially life-threatening
and must be ruled out first. Other relatively common neu-
rologic concerns include post-ictal paralysis or one of the
various motor neuron diseases. Diagnosis of these disor-
ders requires obtaining a complete history with special
consideration of timing, duration, and distribution of
symptoms. Periodic Paralysis is often overlooked in the
initial work-up.
There are several types of Periodic Paralysis associated
with metabolic and electrolyte abnormalities. Of these,
Hypokalemic Periodic Paralysis (HPP) is the most com-
mon with a prevalence of 1 in 100,000 [1]. The clinical
features of the syndrome vary somewhat depending on
the underlying etiology but the most striking feature is the
sudden onset of weakness ranging in severity from mild,
transient weakness to severe disability resulting in life-
threatening respiratory failure. Attacks may be provoked
by stress such as a viral illness or fatigue, or certain medi-
cations such as beta-agonists, insulin or steroids. A pertur-
bation of sodium and calcium ion channels results in low
potassium levels and muscle dysfunction [2]. As this is
primarily a problem with muscle contraction rather than
nerve conduction, tendon reflexes may be decreased or
absent but sensation is generally intact. Although the
serum potassium level is often alarmingly low, other elec-
trolytes are usually normal. Indeed, total body potassium
is actually normal with the change in the serum level
reflecting a shift of potassium into cells [3]. Electrocardio-
graphic changes are common, but unlike patients who are
truly potassium depleted (Table 2), the changes do not
correlate well with the measured serum level [4]. Diagno-
sis between paralytic episodes is difficult as the patient
may have normal strength and potassium levels. Electro-
myography reveals abnormalities in some patients but is
often normal, especially between episodes when no clini-
cally detectable weakness is present.
HPP occurs in several settings and the diagnosis may
require an extensive search for the underlying etiology
since the treatment varies according to the cause. HPP
may occur sporadically in the form of Familial Hypokal-
mic Paralysis (FHP), a poorly understood disorder which
may occur spontaneously or as the result of autosomal
dominant inheritance [1]. This form of Periodic Paralysis
is felt to be the result of disordered cellular potassium reg-
ulation perhaps due to sodium or calcium channel abnor-
malities [2,5]. Mutations of the CACNA1S and SCN4A
genes have been identified that cause abnormalities in
sodium channels resulting in abnormal potassium ion
flux. Acute paralytic episodes are treated with potassium
replacement and close monitoring of the cardiac rhythm
and serum potassium levels. Spironolactone and aceta-
zolamide have been used for prophylaxis with some suc-
cess although long-term potassium supplementation may
be necessary [2].
Thyrotoxic Periodic Paralysis (TPP) occurs in the setting of
hyperthyroidism. It is the most common form of HPP and
is seen primarily in Asian males occurring in 1.9% of Jap-
anese hyperthyroid patients overall and up to 8% of
Table 1: Causes of acute weakness
Neurologic
Stroke
Post-seizure paralysis
Myasthenia gravis
Cataplexy
Multiple sclerosis
Inflammatory
Polymyositis
Dermatomyositis
Infectious
Polio
Diphtheria
Botulism
Metabolic
Porphyria
Alcohol/Opiates
Electrolyte disorders
Table 2: Causes of Hypokalemia
Potassium Depletion – Renal
Increased aldosterone
Diuretics
Hypomagnesemia
Renal Tubular Acidosis (Type I and II)
Metabolic alkalosis
Liddle's syndrome
Potassium Depletion – Extra-renal
Decreased intake
Vomiting/Diarrhea
Zollinger-Ellison Syndrome
Fistulas
Potassium Shift into Cells
Increased insulin
Alkalosis
Thyrotoxic Periodic Paralysis
Familial Hypokalemic ParalysisCases Journal 2008, 1:256 http://www.casesjournal.com/content/1/1/256
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hyperthyroid Japanese men [6,7]. Hispanic males are also
at risk and several cases have been reported [8]. The clini-
cal features are similar to those seen with other forms of
HPP, but also include the symptoms of thyrotoxicosis
such as weight loss, tachycardia, and anxiety. In patients
who develop HPP, however, the symptoms of hyperthy-
roidism are often quite mild and may be overlooked [4,9].
Paralytic episodes often occur at night, as was the case
with this patient [9]. Any cause of hyperthyroidism can be
associated with TPP but Grave's disease is the most com-
mon. The major feature distinguishing TPP from other
Periodic Paralyses is the association of paralytic episodes
with the hyperthyroid state. Paralytic episodes can be
induced in these patients by administering insulin and
glucose, but only when they are hyperthyroid [3]. Euthy-
roid patients are typically free from spontaneous and
induced attacks. The underlying mechanism is not known
but is thought to be different from that of FHP since, in
that disorder, thyroid hormone levels are normal and the
administration of exogenous thyroid hormone does not
result in paralytic episodes. Furthermore, the genetic
abnormalities felt to be responsible for FHP have not been
identified in patients with TPP [5]. Although acute para-
lytic episodes are treated with potassium replacement,
prophylactic potassium or acetazolamide administration
is not felt to benefit these patients since potassium levels
are normal between episodes and may result in dangerous
hyperkalemia [10]. Beta-blocking agents may prevent
attacks but the definitive treatment is correction of the
underlying thyrotoxicosis [3].
Rarely, HPP can result from substantial gastrointestinal or
renal potassium losses. In these cases, total body potas-
sium is depleted and requires aggressive replacement.
Endocrine abnormalities such as hyperinsulinemia and
primary hyperaldosteronism have been associated with
HPP [11]. Surgical removal of the aldosterone producing
tumor is the preferred treatment although symptoms can
often be managed with spironolactone.
Hyperkalemic Periodic Paralysis and Paramyotonia Con-
genita are rare forms of Periodic Paralysis that are also
associated SCN4A mutations that cause gain-of-function
abnormalities in the sodium channel resulting in pro-
longed muscle cell excitation [12]. As a result these condi-
tions worsen with repetitive activity and, in some cases,
exposure to cold. Patients often have paralysis of the facial
muscles and lower extremities are less affected. Most
patients do not require treatment but are instructed to
avoid paralysis-inducing situations. There may be some
benefit of mexiletine which makes muscle tissue less sen-
sitive to nerve impulses.
Anderson Tawil syndrome is a rare, autosomal dominant
disorder that is caused by mutation of the KCNJ2 gene in
60% of cases [12]. Mutation of this gene alters the struc-
ture and function of potassium channels disrupting the
flow of potassium ions in muscle cells leading to Periodic
Paralysis and long QT syndrome. Acetazolamide may pre-
vent the paralytic episodes and antiarrhythmics or beta-
blockers may prevent ventricular ectopy, but there is little
data available.
Conclusion
This patient presented with sudden onset paralysis and
markedly abnormal potassium, TSH, T3 and T4 levels but
no significant symptoms of hyperthyroidism. This presen-
tation is typical of TPP. The paralysis resolved completely
following potassium replacement and he began a course
of methimazole prior to being discharged from the hospi-
tal. At the time of discharge, he had no neurologic find-
ings and a normal blood pressure of 126/88 and pulse of
68. He has not suffered any further episodes of paralysis
and his TSH is now in the normal range.
Periodic Paralysis is important to consider when seeing a
patient with sudden onset weakness or paralysis, espe-
cially those with no history or evidence of other diseases
and no significant risk factors for stroke. Failure to prop-
erly diagnose and treat Periodic Paralysis can be fatal, but
rapid correction of potassium abnormalities can resolve
the symptoms quickly and completely. When possible,
the underlying cause must be adequately addressed to pre-
vent the persistence or recurrence of paralysis.
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